Literature DB >> 12717121

Evidence-based practice and neuromuscular monitoring: it's time for routine quantitative assessment.

Lars I Eriksson.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12717121     DOI： 10.1097/00000542-200305000-00002

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  14 in total

1.  Feasibility of intraoperative neuromonitoring during thyroid surgery after administration of nondepolarizing neuromuscular blocking agents.

Authors:  Koung-Shing Chu; Sheng-Hua Wu; I-Cheng Lu; Cheng-Jing Tsai; Che-Wei Wu; Wen-Rei Kuo; Ka-Wo Lee; Feng-Yu Chiang
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

2.  Survey of muscle relaxant effects management with a kinemyographic-based data archiving system: a retrospective quantitative and contextual quality control approach.

Authors:  Cyrus Motamed; Jean Louis Bourgain; Alain D'Hollander
Journal:  J Clin Monit Comput       Date:  2013-07-10       Impact factor: 2.502

Review 3.  Sugammadex: a review of its use in anaesthetic practice.

Authors:  Lily P H Yang; Susan J Keam
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  Lateral spread response monitoring during microvascular decompression for hemifacial spasm. Comparison of two targets of partial neuromuscular blockade.

Authors:  Y H Chung; W H Kim; J J Lee; S-I Yang; S H Lim; D W Seo; K Park; I S Chung
Journal:  Anaesthesist       Date:  2014-02-07       Impact factor: 1.041

5.  Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathing.

Authors:  M Eikermann; S Zaremba; A Malhotra; A S Jordan; C Rosow; N L Chamberlin
Journal:  Br J Anaesth       Date:  2008-06-16       Impact factor: 9.166

6.  Development of an algorithm using clinical tests to avoid post-operative residual neuromuscular block.

Authors:  Christoph Unterbuchner; Manfred Blobner; Friedrich Pühringer; Matthias Janda; Sebastian Bischoff; Berthold Bein; Annette Schmidt; Kurt Ulm; Viktor Pithamitsis; Heidrun Fink
Journal:  BMC Anesthesiol       Date:  2017-08-04       Impact factor: 2.217

7.  Management of Residual Neuromuscular Blockade Recovery: Age-Old Problem with a New Solution.

Authors:  Michael S Green; Archana Gundigi Venkatesh; Ranjani Venkataramani
Journal:  Case Rep Anesthesiol       Date:  2017-03-14

8.  The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade.

Authors:  Soon Ho Cheong; Seunghee Ki; Jiyong Lee; Jeong Han Lee; Myoung-Hun Kim; Dongki Hur; Kwangrae Cho; Se Hun Lim; Kun Moo Lee; Young-Jae Kim; Wonjin Lee
Journal:  Korean J Anesthesiol       Date:  2015-11-25

9.  Reversal agents: do we need to administer with neuromuscular monitoring - an observational study.

Authors:  Shilpa Goyal; Nikhil Kothari; Deepak Chaudhary; Shilpi Verma; Pooja Bihani; Mahaveer Singh Rodha
Journal:  Indian J Anaesth       Date:  2018-03

10.  Dose-reversal effect relationship of three different doses of neostigmine in obese patients: A randomised clinical trial.

Authors:  Satyen Parida; Venkatesan Kausalya; Sandeep Kumar Mishra; Sethuramachandran Adinarayanan
Journal:  Indian J Anaesth       Date:  2017-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.